StockFin.ai
/
Sign inTry Free

Tools

Search Companies
News & Filings
Insights & Articles
FeaturesComing Soon
Pricing

Strides Pharma Science Ltd (STAR) — Sustainability Report | 23 September 2026

· BSE 🟡 Notable Neutral
By StockFin Research Team•AI-Assisted Analysis•Source: BSE/NSE Filings
📢 Key Event
Strides Pharma Science Limited published its FY26 Sustainability Report, aligning with GRI, SASB, and UNGC standards to detail ESG progress and future targets.
🔄 What Changed
Renewable energy usage increased to 45% in India; Scope 1 and 2 emissions intensity reduced to 1.16 tCO₂e/₹ Mn; 199 suppliers assessed on ESG; 71 attended capacity-building workshops; 100% of Indian sites certified under ISO 14001; Board diversity target of 25% women directors by FY28 set.
🔮 What's Next
Targets include achieving 42% reduction in Scope 1 and 2 emissions by FY30, net zero by FY50, 25% women representation on Board by FY28, and 60% independent directors on Board. Third-party audit of risk management processes to be completed by FY27. Supplier assessments to expand to all critical suppliers.
💡 Investor Takeaway
Strides demonstrates strong ESG integration with measurable climate targets, robust governance, and community impact, reducing risks while enhancing long-term value creation for shareholders through sustainable operations and stakeholder engagement.

Strides Pharma Science Limited released its FY26 Sustainability Report, detailing ESG performance across environmental stewardship, social impact, and governance. The report highlights progress in climate action, water stewardship, waste reduction, and renewable energy adoption (45% in India), alongside robust governance frameworks, board diversity, and risk management. It underscores commitments to Science-Based Targets, biodiversity conservation, and community health initiatives, including healthcare access in Africa and education programs. The report is verified by DNV and aligns with GRI, SASB, and UNGC standards, reflecting Strides' integrated approach to sustainable value creation and long-term resilience.

📄 View Original Announcement (PDF)

📊 Stock Analysis — STAR✨ Ask AI About This

About Strides Pharma Science Ltd (STAR)

Healthcare · Pharmaceuticals · Listed on BSE

Market Cap: ₹10,612.31 CrP/E: 17.3ROE: 19.7%ROCE: 19.2%Div Yield: 0.43%

View full STAR stock details →

📡 Get AI alerts when STAR files next

Free • Daily 5 PM digest • Track filings, board meetings, and corporate actions

Track STAR — Free

💡 Ask AI about this filing

"How will Strides achieve its Science-Based Targets for emissions reduction by FY30 and net zero by FY50?""What is the timeline and methodology for expanding supplier ESG assessments to 100% critical suppliers?""How will the 25% women director target on the Board be achieved by FY28?"
Ask AI Free →

📊 More STAR filings

See all STAR filings →

🔥 Also filed on 23 September 2026

PFOCUSPrime Focus LtdAnnouncement501261Lords Mark Industries LimitedAnnouncementGREENPOWEROrient Green Power Company LtdCorporate ActionPFOCUSPrime Focus LtdAnnouncementGSFCGujarat State Fertilizers & Chemicals LtdAnnouncementGLENMARKGlenmark Pharmaceuticals LtdAnnouncement
View all today's announcements →

Source: Stock Announcements. Analysis by StockFin.ai. For informational purposes only — not investment advice.

Editorial & Data Transparency Notice

This analysis was programmatically compiled using StockFin AI utilizing official regulatory disclosures from the BSE and NSE. Content is automatically synthesized and audited against public financial filings. StockFin.ai is an educational research platform and is NOT a SEBI-registered investment advisor or research analyst.

📡 Get AI alerts when STAR files new disclosures

Track STAR filings, board meetings, and corporate actions. Free email alerts at 5 PM.

Track STAR — Free

Free account · 2 AI queries/day